TrialHuman vaccines & immunotherapeutics2024

Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial.

Tao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.